Summary
We investigated the effect of ICS 205-930 [(3α-tropanyl)-1H-indole-3-carboxylic acid ester], a selective antagonist at 5-HT3 receptors, on the cardiogenic hypertensive chemoreflex in the anaesthetized dog. The reflex was elicited by injection of 5-HT (12.5–1600 μg) into the left cardiac ventricle and consisted of a dose-dependent systemic hypertension associated with a decrease in heart rate. ICS 205-930 (10, 30, and 100 μg/kg i.v.) caused a displacement to the right of both the dose-response curves of 5-HT-induced blood pressure increase and heart rate reduction. Its blocking effects upon the action of 5-HT could be surmounted by increasing the dose of the agonist. The selective 5-HT2 receptor antagonist, ketanserin (0.1 mg/kg i.v.) and the combined 5-HT1 and 5-HT2 receptor antagonist, methiothepin (0.1 mg/kg i.v.) had no influence on the hypertensive reflex. When the reflex was elicited by the ganglionic stimulant, 1,1-dimethyl-4-phenyl-piperazinium (DMPP; 100–1600 μg), ICS 205-930 had no blocking effect. The results suggest that the 5-HT-induced cardiogenic hypertensive chemoreflex is mediated by 5-HT3 receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Coker SJ, Dean HG, Kane KA, Parratt JR (1986) The effects of ICS 205–930, a 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion. Eur J Pharmacol 127:211–218
Eckstein RW, Rowen HE Jr, Shintani F, Shimomura K (1969) Identification of canine left coronary arterial branch in which serotonin initiates reflex pressor response (Abstract). Fed Proc 28:710
Eckstein RW, Shintani F, Rowen HE Jr, Shimomura K, Ohya N (1971) Identification of left coronary blood supply of aortic bodies in anesthetized dogs. J Appl Physiol 30:488–492
Fozard JR (1984) MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36–44
Fozard JR, Mwaluko GMP (1976) Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Br J Pharmacol 57:115–125
Hageman GR, Urthaler F, James TN (1977) Cyproheptadine blockade of a cardiogenic hypertensive chemoreflex. Proc Soc Exp Biol Med 154: 578–581
Hageman GR, Urthaler F, James TN (1978) Neural pathways of a cardiogenic hypertensive chemoreflex. Am J Physiol 235: H345-H349
Hageman GR, James TN, Urthaler F (1980) Blocking effects of cyproheptadine and methysergide upon two different cardiovascular responses to serotonin. Proc Soc Exp Biol Med 165:420–423
Holmsen H (1985) Platelet activation and serotonin. In: Vanhoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York, pp 75–86
Humphrey PPA, Feniuk W, Watts AD (1983) Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system. Fed Proc 42:218–222
James TN, Isobe JH, Urthaler F (1975) Analysis of components in a cardiogenic hypertensive chemoreflex. Circulation 52: 179–192
James TN, Urthaler F, Hageman GR (1976) Chemoreceptors of the cardiogenic hypertensive chemoreflex. Trans Am Clin Climatol Assoc 88:18–31
Lown B (1984) Cardiovascular collapse and sudden cardiac death. In: Braunwald E (ed) Heart disease. A text book of cardiovascular medicine. Saunders, Philadelphia, p 786
Pantridge JF (1978) Autonomic disturbance at the onset of acute myocardial infarction. In: Schwartz PJ, Brown AM, Malliani A, Zanchetti A (eds) Neural mechanisms in cardiac arrhythmias. Raven Press, New York, pp 7–17
Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. Trends in Neurosciences 9:424–428
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131
Robertson D, Hollister AS, Forman MB, Robertson RM (1985) Reflexes unique to myocardial ischemia and infarction. J Am Coll Cardiol 5:99B-104B
Roughgarden JW, Newman EV (1966) Circulatory changes during the pain of angina pectoris 1772–1965. A critical review. Am J Med 41:935–946
Rowen HE Jr, Shimomura K, Eckstein RW (1968) Specific cardiovascular reflexes induced by serotonin in the canine septal artery (Abstract). Fed Proc 27:326
Scholtysik G (1987) Evidence for inhibition by ICS 205–930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. Naunyn-Schmiedeberg's Arch Pharmacol 335:692–696
Scholtysik G, Imoto Y, Yatani A, Brown AM (1988) 5-Hydroxytryptamine antagonist ICS 205–930 blocks cardiac potassium, sodium and calcium currents. J Pharmacol Exp Ther 245:773–778
Williams FM, Rothaul AL, Kane AH, Parratt JR (1985) Antiarrhythmic and electrophysiological effect of ICS 205–930, an antagonist of 5-hydroxytryptamine at peripheral receptors. J Cardiovasc Pharmacol 7:550–555.
Author information
Authors and Affiliations
Additional information
Send offprint requests to H. Berthold at the above address
Rights and permissions
About this article
Cite this article
Berthold, H., Scholtysik, G. & Engel, G. Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205-930. Naunyn-Schmiedeberg's Arch Pharmacol 339, 259–262 (1989). https://doi.org/10.1007/BF00173574
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173574